Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations

摘要

We studied the stability of freeze-dried therapeutic protein formulations over a range of initial concentrations (from 40 to 160 mg/mL) and employed a variety of formulation strategies (including buffer-free freeze dried formulations, or BF-FDF).